Follicle stimulating hormone. International standards and reference preparations for the calibration of immunoassays and bioassays

Clinica Chimica Acta

Volumn 273, Issue 2, 1998, Pages 103-117

  Rose, Matthew P ^a  

^a NATIONAL INSTITUTE FOR BIOLOGICAL STANDARDS AND CONTROL   (United Kingdom)

Author keywords

Bioassays; Follicle stimulating hormone (FSH); Immunoassays; Standards; Therapeutics

Indexed keywords

FOLLITROPIN; HUMAN MENOPAUSAL GONADOTROPIN; LUTEINIZING HORMONE; RECOMBINANT FOLLITROPIN; UROFOLLITROPIN;

BIOASSAY; CALIBRATION; IMMUNOASSAY; INTERNATIONAL STANDARD UNIT; PRIORITY JOURNAL; REVIEW; STANDARD; STANDARDIZATION;

EID: 0032565715     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-8981(98)00042-4     Document Type: Article

References (43)

1. [1] The immunoassay kit directory, Volume 1, Part I, Peptide Hormones. Seth J, editor. Kluwer Academic Publishers, Lancaster, UK, 1991.
2. [2] Taylor AE, Khoury RH, Crowley WRJ. A comparison of 13 different immunometric assay kits for gonadotrophins: Implications for clinical investigation. J Clin Endocrinol Metab 1994;79:240-7.
3. [3] Seth J, Hanning I, Bacon RRA, Hunter WM. Progress and problems in immunoassays for serum pituitary gonadotrophins: evidence from the UK external quality assessment schemes, (EQAS) 1980-1988. Clin Chim Acta 1989;186:67-82.
4. [4] Jockenhovel F, Khan SA, Nieschlag E. Varying dose-response characteristics of different immunoassays and an in vitro bioassay for FSH are responsible for changing ratios of biologically active to immunologically active FSH. J Endocrinol 1990;127:523-32.
5. [5] Steelman SL, Pohley FM. Assay of follicle-stimulating hormone based on augmentation with human chorionic gonadotropin. Endocrinology 1953;53:604-16.
6. [6] Simoni M, Nieschalg E. In vitro bioassays for follicle stimulating hormone: methods and clinical applications. J Endocrinol Invest 1991;14:983-97.
7. [7] Storring PL, Bangham DR. International Reference Standards and the quantification of gonadotrophins. In: Gonadotropin ipofisarie e proalttina, Meeting held at Palazzo dei Congressi, Firenze 19-20 Ottobre, 1984:317-25.
8. [8] Canadian Society of Clinical Chemists Position Paper: Standardization of selected poly-peptide hormone measurements. Clin Biochem 1992;26:415-24.
9. [9] Garrett PE. Troubleshooting immunoassays: The enigma of standardization for LH and FSH assays. J Clin Immunoassay 1989;12:18-20.
10. [10] WHO Expert Committee on Biological Standardization WHO Tec. Rep Series 625 Annex 4 World Health Organisation Geneva, 1978.
11. [11] WHO Expert Committee on Biological Standardization WHO Tec. Rep. Series 760 Annex 3 World Health Organisation Geneva, 1987.
12. [12] WHO Expert Committee on Biological Standardization WHO Tec Rep. Series. 760 Amendment to Annex 3 World Health Organisation Geneva, 1987.
13. [13] Bangham DR. Standardization in peptide hormone immunoassays. Clin Chem 1976;22:957-63.
14. [14] Ekins R. Immunoassay standardization. Proceedings of 3rd IFCC/Bergmeyer. Conference on Improvement of Comparability and Compatibility of Laboratory Assay Results in Life Sciences. Immunoassay Standardization. Scand J Clin Lab Invest 1991;51(Suppl. 205):33-46.
15. [15] Wide L, Hobson BM. Qualitative differences in follicle stimulating hormone activity in the pituitaries of young women compared to that of men and elderly women. J Clin Endocrinol Metab 1983;56:371-5.
16. [16] Harsch IA, Simoni M, Nieschlag E. Molecular heterogeneity of serum follicle stimulating hormone in hypogonadal patients before and during androgen replacement therapy and in normal men. Clin Endocrinol 1993;39:173-80.
17. [17] Papandreou M, Asteria C, Pettersson K, Ronin C, Beck-Peccoz P. Concanavalin A affinity chromatography of human serum gonadotrophins: evidence for changes of carbohydrate structure in different clinical conditions. J Clin Endocrinol Metab 1993;76:1008-13.
18. [18] Creus S, Pellizzari E, Cigorraga SB, Campo S. FSH isoforms: bio-and immuno-activities in post-menopausal and normal menstruating women. Clin Endocrinol 1996;44:181-9.
19. [19] Burgon PG, Robertson DM, Stanton PG, Hearn MTW. Immunological activities of highly purified isoforms of human FSH correlate with in vitro bioactivities. J Endocrinol 1993;139:511-8.
20. [20] Chappel S. Editorial: Biological to immunological ratios: Re-evaluation of a concept. J Clin Endocrinol Metab 1990;70:1494-5.
21. [21] Demir A, Alfthan H, Stenman U, Voutilainen R. A clinically useful method for detecting gonadotrophins in children: assessment of luteinizing hormone and follicle stimulating hormone from urine as an alternative to serum by time-resolved immunofluorometric assays. Ped Res 1994;36:221-6.
22. [22] Kulin H, Demers L, Chinchilli V, Martel J, Santoro N. Usefulness of sequential urinary follicle-stimulating hormone and luteinizing hormone measurements in the diagnosis of adolescent hypogonadotropism in males. J Clin Endocrinol Metab 1994;78:1208-11.
23. [23] Meeting Report prepared by Bangham DR, Borth R. Assay of protein hormones related to human reproduction: problems of specificity of assay methods and reference methods. Purity of standards. Acta Endocrinologica 1972:71625-37.
24. [24] Hard K, Mekking A, Damm JBL et al. Isolation and structure determination of the intact sialylated N-linked carbohydrate chains of recombinant human follitropin expressed in Chinese hamster ovary cells. Eur J Biochem 1990;193:263-71.
25. [25] Rose MP, Gaines-Das RE. Characterisation and comparison by international collaborative study of international standards (IS) for the calibration of therapeutic preparations of follicle stimulating hormone (FSH). J Endocrinol (in press).
26. [26] Out HJ, Mannaerts BMJL, Driessen SGAJ, Coelingh-Bennink HJT. A prospective, randomised assessor - blind, multicentre study comparing recombinant and urinary follicle stimulating hormone (Puregon v Metrodin) in vitro fertilization. Hum Reprod 1995;10:2534-40.
27. [27] Mulders JWM, Derksen M, Swolfs A, Maris F. Prediction of the in vivo biological activity of human recombinant follicle stimulating hormone using quantitative isoelectric focusing. Biologicals 1997;25:269-81.
28. [28] WHO Expert Committee on Biological Standardization WHO Tec. Rep Series. 293 World Health Organisation Geneva, 1964:12.
29. [29] Bangham DR, Berryman I, Burger H et al. An international collaborative study of 69/104, a reference preparation of human pituitary FSH and LH. J Clin Endocrinol Metab 1973;36:647-60.
30. [30] WHO Expert Committee on Biological Standardization WHO Tec. Rep. Series 565 World Health Organisation Geneva, 1975:12.
31. [31] WHO Expert Committee on Biological Standardization WHO Tec. Rep. Series. 658 World Health Organisation Geneva, 1981:24.
32. [32] WHO Expert Committee on Biological Standardization WHO Tec. Rep Series. 760 World Health Organisation Geneva, 1987:24-5.
33. [33] Starring PL, Gaines-Das RE. The International Standard for Pituitary FSH: collaborative Study of the standard and four other purified human FSH preparations of differing molecular composition by bioassays, receptor assays and different immunoassay systems. J Endocrinol 1989;123:275-93.
34. [34] Simoni M, Jockenhovel F, Nieschlag E. Biological and immunological properties of the international standard for FSH 83/575: isoelectricfocusing profile and comparison with other FSH preparations. Acta Endocrinol 1993;128:281-8.
35. [35] Vermes I, Bonte HA, van der Sluijs-Veer G, Schoemaker J. Interpretations of five monoclonal immunoassays of lutropin and follitropin: effects of normalisation with WHO Standard. Clin Chem 1991;37:415-21.
36. [36] WHO Expert Committee on Biological Standardization WHO Tec. Rep. Series. 565 World Health Organisation Geneva, 1975:6.
37. [37] Starring PL, Dixon H, Bangham DR. The first international standard for human urinary FSH and LH (ICSH), for bioassay. Acta Endocrinol 1976;83:700-10.
38. [38] WHO Expert Committee on Biological Standardization WHO Tec. Rep. Series. 786 World Health Organisation Geneva, 1989:21-2.
39. [39] WHO Expert Committee on Biological Standardization WHO Tec. Rep. Series. 848 World Health Organisation Geneva, 1994:19.
40. [40] Loumaye E, Martineau I, Piazzi A. Clinical assessment of human gonadotrophins produced by recombinant DNA technology. Hum Reprod 1996;11(Suppl 1):95-107.
41. [41] Heikoop JE, Van den Beuningen MJACM, van den Boogaart P, Grootenhuis PDJ. Evaluation of subunit truncation and the nature of the spacer for single chain human gonadotrophins. Eur J Biochem 1997;245:656-62.
42. [42] Heikoop JC, van den Boogaart P, Mulders JWM, Grrotenhuis PDJ. Structure-based design and protein engineering of intersubunit disulfide bonds in gonadotropins. Nature Biotechnol 1997;15:658-62.
43. [43] Jeffocate SL. Standardization of human follicle-stimulating hormone for therapy and diagnosis: Report of an International Workshop, National Institute for Biological Standards and Control, LTK, 21-22 March 1996. Clin Endocrinol 1997;46:527-9.